4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives. II. Their renal vasodilation activity and structure-activity relationship

Chemical and Pharmaceutical Bulletin

Volumn 44, Issue 10, 1996, Pages 1865-1870

  Anan, Hideki ^a   Tanaka, Akihiro ^a   Tsuzuki, Ryuji ^a   Yokota, Masaki ^a   Yatsu, Takeyuki ^a   Fujikura, Takashi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

4 phenyltetrahydroisoquinoline; DA1; methanesulfonamide; renal vasodilation; structure activity relationship

Indexed keywords

4 (3,4 DIHYDROXYPHENYL) 1,2,3,4 TETRAHYDRO 7,8 DIHYDROXYISOQUINOLINE; 4 (3,4 DIHYDROXYPHENYL) 7 METHANESULFONAMIDO 1,2,3,4 TETRAHYDROISOQUINOLINE; DOPAMINE 1 RECEPTOR; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL TISSUE; ARTICLE; DOG; DRUG CONFORMATION; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FEMALE; KIDNEY BLOOD VESSEL; MALE; NONHUMAN; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; VASODILATATION;

EID: 0029852939     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.44.1865     Document Type: Article

References (12)

1. Previous report: Anan H., Tanaka A., Tsuzuki R., Yokota M., Yatsu T., Honda K., Asano M., Fujita S., Furuya T., Fujikura T., Chem. Pharm. Bull., 39, 2910-2914 (1991).
2. Cavero I., Massingham R., Lefèvre-Borg F., Life Sci., 31, 939-948 (1982).
3. Tanaka A., Fujikura T., Tsuzuki R., Yokota M., Yatsu T., Eur. Patent Appl. EP286293 (1988) [Chem. Abstr., 110, 95022k (1989)].
4. a) Hahn R. A., Wardell J. R., Jr., Sarau H. M., Ridley P. T., J. Pharmacol. Exp. Ther., 223, 305-313 (1982)
5. b) Kinter L. B., Mann W. A., Weinstock J., Ruffolo R. R., Jr., Chirality, 6, 446-455 (1994).
6. Bobbitt J. M., Shibuya S., J. Org. Chem., 35, 1181-1183 (1970).
7. Hodgson H. H., Chem. Rev., 40, 251-277 (1947).
8. Goldberg L. I., Kohli J. D., Kotake A. N., Volkman P. H., Fed. Proc., Fed. Am. Soc. Exp. Biol., 37, 2396-2402 (1978).
9. a) Iorio L. C., Barnett A., Leitz F. H., Houser V. P., Korduba C. A., J. Pharmacol. Exp. Ther., 226, 462-468 (1983)
10. b) Hyttel J., Eur. J. Pharmacol., 91, 153-154 (1983).
11. Riggs R. M., Nichols D. E., Foreman M. M., Truex L. L., Glock D., Kohli J. D., J. Med. Chem., 30, 1454-1458 (1987).
12. BrennerL. M., Wardell J. R., Jr., Eur. Patent Appl. EP40956 (1981) [Chem. Abstr., 96, 162552r (1982)].